The relation between naturalistic use of psychedelics and perception of emotional stimuli: An event-related potential study comparing non-users and experienced users of classic psychedelics
This EEG study compared non-users and individuals with extensive naturalistic psychedelic use (≥15 lifetime experiences) during presentation of emotional facial expressions. Experienced users showed reduced early ERP responses (N170/N200) to fearful faces—suggesting diminished automatic reactivity to negative stimuli—whereas later attention-related components (P200/P300) did not differ between groups.
Authors
- Paweł Orłowski
- Michał Bola
Published
Abstract
Background
Previous research has suggested that controlled administration of psychedelic substances can modulate emotional reactivity, enhancing positive and diminishing negative emotions. However, it is unclear whether similar effects are associated with using psychedelics in less-controlled naturalistic environments.
Aims
This cross-sectional study investigated the neural markers associated with the perception of emotional stimuli in individuals with extensive experience of naturalistic psychedelic use (15 or more lifetime experiences), comparing them to non-users.
Methods
Electroencephalography (EEG) signals were recorded from two groups: experienced psychedelics users ( N = 56) and non-users ( N = 55). Participants were presented with facial images depicting neutral or emotional expressions (anger, sadness, and happiness). Event-related potential (ERP) components were analyzed as indices of emotional reactivity.
Results
Psychedelic users were characterized by significantly lower amplitudes of the N200 component in response to fearful faces, in comparison to non-users. In addition, interaction effects between Group and Emotional expression were observed on N170 and N200 amplitudes, indicating group differences in the processing of fearful faces. However, no significant between-group differences emerged in the analysis of later ERP components associated with attention and cognitive processes (P200 and P300).
Conclusions
The results suggest that naturalistic use of psychedelics may be linked to reduced reactivity to emotionally negative stimuli at the early and automatic processing stages. Our study contributes to a better understanding of the effects related to using psychedelics in naturalistic contexts.
Research Summary of 'The relation between naturalistic use of psychedelics and perception of emotional stimuli: An event-related potential study comparing non-users and experienced users of classic psychedelics'
Introduction
Psychedelics such as psilocybin, LSD, mescaline and DMT produce robust alterations of perception and consciousness, and a growing body of laboratory and clinical research has examined their acute neurophysiological and subjective effects. Earlier experimental studies report that psychedelics can acutely alter behavioural and neural responses to emotional stimuli: for example, reduced recognition of sad and fearful faces, lowered amplitude of face-selective ERP components (N170) to negative faces, reduced P300 responses to negatively valenced words, and decreased amygdala reactivity and connectivity when processing negative emotional cues. Some longitudinal and cross-sectional work further suggests longer-lasting increases in positive affect and decreases in negative affect after psychedelic sessions, but these findings derive mostly from controlled clinical or laboratory settings and self-report measures that are vulnerable to bias. Orłowski and colleagues set out to test whether similar alterations in emotional reactivity are associated with naturalistic use of classic psychedelics (i.e. use outside supervised clinical or lab contexts). The present pre-registered cross-sectional EEG study compared experienced naturalistic psychedelic users (≥15 lifetime experiences) with non-users while participants performed a gender discrimination task on faces showing neutral, angry, fearful or happy expressions. The main hypotheses concerned two pre-registered ERP indices of emotional processing (N170 and P300): users were expected to show attenuated N170 and P300 amplitudes to negative expressions (fear, anger) relative to non-users. Exploratory analyses targeted earlier attention/perception-related components (N200 and P200) to provide a fuller picture of processing from early perceptual stages to later cognitive evaluation.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typeindividual
- Journal
- Topic
- Authors
- APA Citation
Orłowski, P., Hobot, J., Ruban, A., Szczypiński, J., & Bola, M. (2024). The relation between naturalistic use of psychedelics and perception of emotional stimuli: An event-related potential study comparing non-users and experienced users of classic psychedelics. Journal of Psychopharmacology, 38(1), 68-79. https://doi.org/10.1177/02698811231216322
References (31)
Papers cited by this study that are also in Blossom
Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K. et al. · Neuroscience and Biobehavioral Reviews (2020)
Andersen, K. A. A., Carhart-Harris, R. L., Nutt, D. J. et al. · Acta Psychiatrica Scandinavica (2020)
Barrett, F. S., Doss, M. K., Sepeda, N. D. et al. · Scientific Reports (2020)
Carhart-Harris, R. L., Leech, R., Williams, T. M. et al. · British Journal of Psychiatry (2018)
Carhart-Harris, R. L., Roseman, L., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)
Dolder, P. C., Schmid, Y., Müller, F. et al. · Neuropsychopharmacology (2016)
Gattuso, J. J., Perkins, D., Ruffell, S. G. D. et al. · International Journal of Neuropsychopharmacology (2022)
Glynos, N., Fields, C. W., Barron, J. et al. · Journal of Psychoactive Drugs (2022)
Golden, T. L., Magsamen, S., Sandu, C. C. et al. · Current Topics in Behavioral Neurosciences (2022)
Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)
Show all 31 referencesShow fewer
Grimm, O., Kraehenmann, R., Preller, K. H. et al. · European Neuropsychopharmacology (2018)
Hendricks, P. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)
Jiménez-Garrido, D. F., Gómez-Sousa, M., Ona, G. et al. · Scientific Reports (2020)
Kometer, M., Schmidt, A., Bachmann, R. et al. · Biological Psychiatry (2012)
Liechti, M. E., Dolder, P. C., Schmid, Y. · Psychopharmacology (2016)
Milliere, R., Carhart-Harris, R. L., Roseman, L. et al. · Frontiers in Psychology (2018)
Mueller, F., Lenz, C., Dolder, P. C. et al. · Translational Psychiatry (2017)
Perry, C. M., Malina, M. · Psychopharmacology (2021)
Muthukumaraswamy, S., Forsyth, A., Sumner, R. L. · Australian and new-zealand Journal of Psychiatry (2022)
Nayak, S., Jackson, H., Sepeda, N. D. et al. · Frontiers in Psychiatry (2023)
Nichols, C. D., Nichols, D. E., Johnson, M. W. · Clinical Pharmacology and Therapeutics (2016)
Nygart, V., Pommerencke, L. M., Haijen, E. et al. · Journal of Psychopharmacology (2022)
Orłowski, P., Ruban, A., Szczypiński, J. et al. · Journal of Psychopharmacology (2022)
Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Raison, C. L., Jain, R., Jain, S. et al. · Frontiers in Psychiatry (2022)
Rocha, J. M., Osório, F. L., Crippa, J. A. et al. · Therapeutic Advances in Psychopharmacology (2019)
Schmidt, A., Kometer, M., Bachmann, R. et al. · Psychopharmacology (2012)
Simonsson, O., Goldberg, S. B. · Journal of Psychoactive Drugs (2022)
Stoliker, D., Egan, G. F., Friston, K. J. et al. · Pharmacological Reviews (2022)
Vollenweider, F. X., Kometer, M. · Nature Reviews Neuroscience (2010)
Vollenweider, F. X., Preller, K. H. · Nature Reviews Neuroscience (2020)
Cited By (3)
Papers in Blossom that reference this study
Orłowski, P., Domagalik, A., Bola, M. · Human Brain Mapping (2026)
Ruban, A., Magnuski, M., Hobot, J. et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025)
Orłowski, P., Hobot, J., Ruban, A. et al. · Psychophysiology (2024)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.